Stenmax Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in New Delhi, Delhi, India, established in 2019.
2019 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Stenmax Pharmaceuticals Private Limited

Stenmax Pharmaceuticals Private Limited, a active private limited company, was established on 26 November 2019 in New Delhi, Delhi, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24290DL2019PTC358063. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Amresh Kumar Sinha (Director), Rajiv Kumar Singh (Director), Rakesh Kumar Thakur (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H. No. 32, Kh No. 18/3 Nangli Vihar, New Delhi, Delhi, 110043.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290DL2019PTC358063

  • Registration Number

    358063

  • Incorporation Date

    26 November 2019

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Stenmax Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Stenmax Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Stenmax Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Amresh Kumar Sinha Director 16 Dec 2023 Current
Rajiv Kumar Singh Director 26 Nov 2019 Current
Rakesh Kumar Thakur Director 26 Nov 2019 Current
Sanjeev Kumar Das Director 13 Jan 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Stenmax Pharmaceuticals.

Stenmax Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Stenmax Pharmaceuticals revenue growth over time
Stenmax Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Stenmax Pharmaceuticals?

Unlock access to Stenmax Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Stenmax Pharmaceuticals?

Unlock and access historical data on people associated with Stenmax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Stenmax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stenmax Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Stenmax Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Stenmax Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Stenmax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Director Appointment

    Amresh Kumar Sinha was appointed as a Director was appointed as a Director on 16 Dec 2023 & has been associated with this company since 2 years 1 month . was recorded as a recent event.

  • Director Appointment

    Sanjeev Kumar Das was appointed as a Director was appointed as a Director on 13 Jan 2022 & has been associated with this company since 4 years 25 days . was recorded as a recent event.

  • Director Appointment

    The activity Rajiv Kumar Singh was appointed as a Director was appointed as a Director on 26 Nov 2019 & has been associated with this company since 6 years 2 months . was completed.

  • Director Appointment

    Progress on Rakesh Kumar Thakur was appointed as a Director was appointed as a Director on 26 Nov 2019 & has been associated with this company since 6 years 2 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Stenmax Pharmaceuticals Private Limited?

The CIN of Stenmax Pharmaceuticals Private Limited is U24290DL2019PTC358063.

Where is Stenmax Pharmaceuticals Private Limited headquartered?

Stenmax Pharmaceuticals Private Limited is headquartered at H. No. 32, Kh No. 18/3 Nangli Vihar, New Delhi, Delhi, 110043.

When was Stenmax Pharmaceuticals Private Limited incorporated?

Stenmax Pharmaceuticals Private Limited was incorporated on 26 November 2019.

Who are the current directors of Stenmax Pharmaceuticals Private Limited?

The current directors of Stenmax Pharmaceuticals Private Limited are

What is the primary industry of Stenmax Pharmaceuticals Private Limited?

The primary industry of Stenmax Pharmaceuticals Private Limited is Chemicals.

Is Stenmax Pharmaceuticals Private Limited a listed company?

Stenmax Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Stenmax Pharmaceuticals Private Limited?

The authorized capital of Stenmax Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available